{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:23:40Z","timestamp":1772465020126,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00115-025-01838-2","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:08:24Z","timestamp":1748599704000},"page":"188-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Soziodemographische und klinische Daten bei GHB-Patient*innen\u2013 eine Beobachtungsstudie","Sociodemographic and clinical data among GHB patients\u2014an observational study"],"prefix":"10.1007","volume":"97","author":[{"given":"Julia","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Neu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"1838_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/02791072.2014.921746","volume":"46","author":"R Brennan","year":"2014","unstructured":"Brennan\u00a0R, Van Hout\u00a0MC (2014) Gamma-hydroxybutyrate (GHB): a\u00a0scoping review of pharmacology, toxicology, motives for use, and user groups. J\u00a0Psychoactive Drugs 46:243\u2013251. https:\/\/doi.org\/10.1080\/02791072.2014.921746","journal-title":"J Psychoactive Drugs"},{"issue":"8","key":"1838_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jat\/28.8.625","volume":"28","author":"R Brenneisen","year":"2004","unstructured":"Brenneisen\u00a0R, Elsohly\u00a0MA, Murphy\u00a0TP, Passarelli\u00a0J, Russmann\u00a0S, Salamone\u00a0SJ, Watson\u00a0DE (2004) Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. J\u00a0Anal Toxicol 28(8):625\u2013630. https:\/\/doi.org\/10.1093\/jat\/28.8.625","journal-title":"J Anal Toxicol"},{"issue":"4","key":"1838_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/dar.12925","volume":"38","author":"A Curtis","year":"2019","unstructured":"Curtis\u00a0A, Vandenberg\u00a0B, Mayshak\u00a0R, Coomber\u00a0K, Hyder\u00a0S, Walker\u00a0A, Liknaitzky\u00a0P, Miller\u00a0PG (2019) Alcohol use in family, domestic and other violence: Findings from a\u00a0cross-sectional survey of the Australian population. Drug Alcohol Rev 38(4):349\u2013358. https:\/\/doi.org\/10.1111\/dar.12925","journal-title":"Drug Alcohol Rev"},{"key":"1838_CR4","doi-asserted-by":"publisher","first-page":"103230","DOI":"10.1016\/j.drugpo.2021.103230","volume":"94","author":"BAG Dijkstraa","year":"2021","unstructured":"Dijkstraa\u00a0BAG, Beurmanjer\u00a0H, Goudriaand\u00a0AE, Schellekens\u00a0AFA, Joostena\u00a0EAG (2021) Unity in diversity: A\u00a0systematic review on the GHB using population. Int J Drug Policy 94:103230. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103230","journal-title":"Int J Drug Policy"},{"key":"1838_CR5","unstructured":"(2024) European Monitoring Centre for Drugs and Drug Addiction. European drug report. https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2024\/other-drugs_en"},{"key":"1838_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1208\/s12248-020-00543-z","volume":"23","author":"MA Felmlee","year":"2021","unstructured":"Felmlee\u00a0MA, Morse\u00a0BL, Morris\u00a0ME (2021) \u03b3\u2011Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology. AAPS\u00a0J 23:22. https:\/\/doi.org\/10.1208\/s12248-020-00543-z","journal-title":"AAPS J"},{"key":"1838_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2174\/1570159X15666161117151148","volume":"15","author":"R Giorgetti","year":"2017","unstructured":"Giorgetti\u00a0R, Tagliabracci\u00a0A, Schifano\u00a0F, Zaami\u00a0S, Marinelli\u00a0E, Busard\u00f2\u00a0FP (2017) When \u201cChems\u201d meet sex: a\u00a0rising phenomenon called \u201cChemSex\u201d. Curr Neuropharmacol 15:762\u2013770. https:\/\/doi.org\/10.2174\/1570159X15666161117151148","journal-title":"Curr Neuropharmacol"},{"key":"1838_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.drugpo.2018.06.010","volume":"58","author":"J-P Grund","year":"2018","unstructured":"Grund\u00a0J\u2011P, de Bruin\u00a0D, van Gaalen\u00a0S (2018) Going knock-recurrent comatose GHB intoxication in the Netherlands and Flanders (Belgium). Int J Drug Policy 58:137\u2013148. https:\/\/doi.org\/10.1016\/j.drugpo.2018.06.010","journal-title":"Int J Drug Policy"},{"key":"1838_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.psym.2014.03.002","volume":"56","author":"R Kamal","year":"2015","unstructured":"Kamal\u00a0R, van Noorden\u00a0MS, Dijkstra\u00a0BA, Mauritz\u00a0R, de Jong\u00a0C (2015) A case series of pharma ceutical gamma-hydroxybutyrate in 3\u00a0patients with severe benzodiazepine-resistant gamma hydroxybutyrate withdrawal in the hospital. Psychosomatics 56:404\u2013409.","journal-title":"Psychosomatics"},{"key":"1838_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s12028-008-9062-2","volume":"8","author":"JL LeTourneau","year":"2008","unstructured":"LeTourneau\u00a0JL, Hagg\u00a0DS, Smith\u00a0SM (2008) Baclofen and gammahydroxybutyrate withdrawal. Neurocrit Care 8:430\u2013433. https:\/\/doi.org\/10.1007\/s12028-008-9062-2","journal-title":"Neurocrit Care"},{"issue":"2","key":"1838_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1055\/s-2008-1060551","volume":"43","author":"A L\u00fctz","year":"2008","unstructured":"L\u00fctz\u00a0A, Radtke\u00a0FM, Seeling\u00a0M (2008) The Nursing Delirium Screening Scale (NU-DESC). An\u00e4sthesiol Intensivmed Notfallmed Schmerzther 43(2):98\u2013102. https:\/\/doi.org\/10.1055\/s-2008-1060551","journal-title":"An\u00e4sthesiol Intensivmed Notfallmed Schmerzther"},{"issue":"1","key":"1838_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.drugalcdep.2004.01.012","volume":"75","author":"M McDonough","year":"2004","unstructured":"McDonough\u00a0M, Kennedy\u00a0N, Glasper\u00a0A, Bearn\u00a0J (2004) Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a\u00a0review. Drug Alcohol Depend 75(1):3\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2004.01.012","journal-title":"Drug Alcohol Depend"},{"key":"1838_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.12.001","author":"S Mahamad","year":"2019","unstructured":"Mahamad\u00a0S, Hammand\u00a0D (2019) Retail price and availability of illicit cannabis in Canada. Addict Behav. https:\/\/doi.org\/10.1016\/j.addbeh.2018.12.001","journal-title":"Addict Behav"},{"issue":"9","key":"1838_CR14","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1177\/0269881110363315","volume":"24","author":"Z Nemeth","year":"2010","unstructured":"Nemeth\u00a0Z, Kun\u00a0B, Demetrovics\u00a0Z (2010) The involvement of gamma-hydroxybutyrate in reported sexual assaults: a\u00a0systematic review. J\u00a0Psychopharmacol 24(9):1281\u20131287. https:\/\/doi.org\/10.1177\/0269881110363315","journal-title":"J Psychopharmacol"},{"issue":"62","key":"1838_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13722-023-00414-w","volume":"18","author":"P Neu","year":"2023","unstructured":"Neu\u00a0P, Danker-Hopfe\u00a0H, Fisher\u00a0R, Ehlen\u00a0F (2023) GHB\u2014a\u00a0life-threatening drug Complications and outcome of GHB detoxification treatment\u2014an observational clinical study. Addict Sci Clin Pract 18(62):1\u20138. https:\/\/doi.org\/10.1186\/s13722-023-00414-w","journal-title":"Addict Sci Clin Pract"},{"issue":"3","key":"1838_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/089198879801100304","volume":"11","author":"RC van der Mast","year":"2018","unstructured":"van der Mast\u00a0RC (2018) Pathophysiology of Delirium. J\u00a0Geriatr Psychiat Neurol 11(3):138\u2013145. https:\/\/doi.org\/10.1177\/089198879801100304 (discussion 157-8)","journal-title":"J Geriatr Psychiat Neurol"},{"key":"1838_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109741","author":"H Wang","year":"2023","unstructured":"Wang\u00a0H, Jonas\u00a0KJ, Guadamuz\u00a0TE (2023) Chemsex and chemsex associated substance use among men who have sex with men in Asia: A\u00a0systematic review and meta-analysis. Drug Alcohol Depend. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109741","journal-title":"Drug Alcohol Depend"},{"key":"1838_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/dta.292","volume":"3","author":"DM Wood","year":"2011","unstructured":"Wood\u00a0DM, Brailsford\u00a0AD, Dargana\u00a0PI (2011) Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). Drug Test Analysis 3:417\u2013425. https:\/\/doi.org\/10.1002\/dta.292","journal-title":"Drug Test Analysis"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01838-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-025-01838-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01838-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:10:37Z","timestamp":1772460637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-025-01838-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1838"],"URL":"https:\/\/doi.org\/10.1007\/s00115-025-01838-2","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"10 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Martin und P.\u00a0Neu geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle beschriebenen Untersuchungen am Menschen oder an menschlichem Gewebe wurden mit Zustimmung der zust\u00e4ndigen Ethikkommission, im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt. Die Studie wurde vom zust\u00e4ndigen Ethikkomitee (Charit\u00e9\u00a0\u2013 Universit\u00e4tsmedizin Berlin, Referenznummer: EA1\/235\/21) gepr\u00fcft und genehmigt. Alle Teilnehmenden willigten schriftlich in die Studienteilnahme ein.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}